Ma et al. understood that FGFR1 returned the anti-glycolytic activity of miR-361-5p via upregulating the function of LDHA, which supports the mechanism that miR-361-5p hindered breast cancer cell glycolysis and cell proliferation. Here, FGFR1 is linked to breast cancer.